Results
eNauka >
Results >
A novel primeboost therapeutic vaccine induces sustained seroconversion at 52 weeks in patients with HBeAg+ chronic hepatitis B - a phase IIa clinical trial
| Title: | A novel primeboost therapeutic vaccine induces sustained seroconversion at 52 weeks in patients with HBeAg+ chronic hepatitis B - a phase IIa clinical trial | Authors: | Schneider, J.; Halota, W.; Delić, Dragan; Nešić, Zorica   ; Prokopowicz, D.; Flisiak, R.; Kuydowicz, J.; Jablkowski, M.; Cianciara, J.; Mach, T.; |
Issue Date: | 2006 | Publication: | Journal of clinical virology | ISSN: | 1386-6532 Journal of Clinical Virology Search Idenfier |
Publisher: | Tokyo [etc.] : Elsevier | Type: | Conference Paper | Collation: | vol. 36 br. Vol. 36 str. S30-S30 | DOI: | 10.1016/S1386-6532(06)80097-1 | WoS-ID: | 000239067300088 | VBS COBISS: | 1026486453 | URI: | https://plus.cobiss.net/cobiss/sr/sr/bib/1026486453#izum.si https://enauka.gov.rs/handle/123456789/645534 |
M-category: | Mp. category will be shown later |
4
OpenCitations
2
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall
Google ScholarTM
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.